Document is current

Article History

Received: 21 January 2025

Accepted: 15 May 2025

First Online: 17 June 2025

Declarations

:

: Marjorie Argollo served as a speaker, consultant and advisory board member for AbbVie, Janssen, Takeda and Pfizer. Yoon K. An has received consulting fees and speaker fees from AbbVie, Bristol Myers Squibb (BMS), Eli Lilly, Dr Falk, Ferring, GlaxoSmithKline, Janssen, Pfizer, Samsung, Sandoz, Shire and Takeda Pharmaceuticals; advisory board fees from AbbVie, BMS, Chiesi, Janssen, Microba, NPS Medicine Wise, the Council of Therapeutic Advisory Group (CATAG) and Takeda Pharmaceuticals; and research and educational support from AbbVie, BMS, Cannon, Celltrion, Chiesi, Dr Falk, Ferring, Janssen, Pfizer, Samsung, Sandoz, Siemens and Takeda Pharmaceuticals. Nahla Azzam served on advisory boards and received speaker fees and/or consultation fees from AbbVie, Takeda, Janssen, Ferring, Falk, Sandoz, Hikma, Pfizer, BMS and Organon; Dr. Azzam has received research funding from Pfizer and AbbVie. Dr Domingo C. Balderramo reports speaker fees from AbbVie, Takeda and Janssen and consulting fees from AbbVie, Takeda, Janssen, Pfizer and Amgen. Olga Fadeeva is an employee of Takeda Pharmaceuticals International AG, Singapore, and holds Takeda stock. Chia-Jung Kuo has no conflicts to disclose. Julie Laurent is an employee of Else Care (Carenity) who received funding to conduct the present study. Elenore Uy is an employee of Takeda Pharmaceuticals International AG, Singapore, and holds Takeda and AbbVie stocks.

: The study was conducted in accordance with the study protocol, the current version of the Declaration of Helsinki, the International Society of Pharmacoepidemiology Guidelines for Good Pharmacoepidemiology Practices [], any local regulations and the General Data Protection Regulation. As EC submission is mandatory for any survey involving human participants in Brazil, the protocol was reviewed and approved by the Brazil local ethics committee (EC; CEP, Comitês de Ética em Pesquisa) and the National EC (CONEP, Comissão Nacional de Ética em Pesquisa), Certificate of Presentation for Ethical Consideration (Certificado de Apresentação para Ética em Pesquisa), CAAE 66895823.5.0000.5487. Before participating in the study, all patients completed an informed consent form that was translated into the language of the questionnaire. Survey respondents were compensated for their participation. The value and mode of compensation varied depending on local regulations and the time required to complete the survey.